CDT vs. VOOG

Last updated Apr 1, 2026

Compare and contrast key facts about Conduit Pharmaceuticals Inc. (CDT) and Vanguard S&P 500 Growth ETF (VOOG).

VOOG is a passively managed fund by Vanguard that tracks the performance of the S&P 500 Growth Index. It was launched on Apr 5, 2019.

Performance

CDT vs. VOOG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Conduit Pharmaceuticals Inc. (CDT) and Vanguard S&P 500 Growth ETF (VOOG). The values are adjusted to include any dividend payments, if applicable.

CDT vs. VOOG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
CDT Conduit Pharmaceuticals Inc.	-84.06%	-99.84%	-98.49%	-56.17%
VOOG Vanguard S&P 500 Growth ETF	-6.97%	22.11%	35.89%	9.15%

Returns By Period

In the year-to-date period, CDT achieves a -84.06% return, which is significantly lower than VOOG's -6.97% return.

CDT

• 1D: -45.45%
• 1M: -70.55%
• YTD: -84.06%
• 6M: -96.25%
• 1Y: -99.78%
• 3Y*: —
• 5Y*: —
• 10Y*: —

VOOG

• 1D: 1.30%
• 1M: -4.28%
• YTD: -6.97%
• 6M: -5.29%
• 1Y: 23.21%
• 3Y*: 22.32%
• 5Y*: 12.46%
• 10Y*: 15.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CDT vs. VOOG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CDT

CDT Risk / Return Rank: 7
CDT Sharpe Ratio Rank: 13
CDT Sortino Ratio Rank: 0
CDT Omega Ratio Rank: 0
CDT Calmar Ratio Rank: 1
CDT Martin Ratio Rank: 20

VOOG

VOOG Risk / Return Rank: 62
VOOG Sharpe Ratio Rank: 57
VOOG Sortino Ratio Rank: 61
VOOG Omega Ratio Rank: 60
VOOG Calmar Ratio Rank: 67
VOOG Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDT vs. VOOG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Conduit Pharmaceuticals Inc. (CDT) and Vanguard S&P 500 Growth ETF (VOOG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CDT	VOOG	Difference
Sharpe ratio Return per unit of total volatility	-0.65	1.05	-1.70
Sortino ratio Return per unit of downside risk	-4.23	1.62	-5.85
Omega ratio Gain probability vs. loss probability	0.52	1.23	-0.71
Calmar ratio Return relative to maximum drawdown	-1.00	1.76	-2.76
Martin ratio Return relative to average drawdown	-1.12	6.81	-7.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CDT vs. VOOG - Sharpe Ratio Comparison

The current CDT Sharpe Ratio is -0.65, which is lower than the VOOG Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of CDT and VOOG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CDT	VOOG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.65	1.05	-1.70
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.59	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.77	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.56	0.84	-1.40

Correlation

The correlation between CDT and VOOG is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CDT vs. VOOG - Dividend Comparison

CDT has not paid dividends to shareholders, while VOOG's dividend yield for the trailing twelve months is around 0.53%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CDT Conduit Pharmaceuticals Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VOOG Vanguard S&P 500 Growth ETF	0.53%	0.49%	0.49%	1.12%	0.93%	0.53%	0.88%	1.26%	1.34%	1.32%	1.47%	1.56%

Drawdowns

CDT vs. VOOG - Drawdown Comparison

The maximum CDT drawdown since its inception was -100.00%, which is greater than VOOG's maximum drawdown of -32.73%. Use the drawdown chart below to compare losses from any high point for CDT and VOOG.

Drawdown Indicators

	CDT	VOOG	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-32.73%	-67.27%
Max Drawdown (1Y) Largest decline over 1 year	-99.84%	-13.71%	-86.13%
Max Drawdown (5Y) Largest decline over 5 years	—	-32.73%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-32.73%	—
Current Drawdown Current decline from peak	-100.00%	-9.07%	-90.93%
Average Drawdown Average peak-to-trough decline	-90.69%	-5.01%	-85.68%
Ulcer Index Depth and duration of drawdowns from previous peaks	88.88%	3.54%	+85.34%

Volatility

CDT vs. VOOG - Volatility Comparison

Conduit Pharmaceuticals Inc. (CDT) has a higher volatility of 72.92% compared to Vanguard S&P 500 Growth ETF (VOOG) at 7.28%. This indicates that CDT's price experiences larger fluctuations and is considered to be riskier than VOOG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CDT	VOOG	Difference
Volatility (1M) Calculated over the trailing 1-month period	72.92%	7.28%	+65.64%
Volatility (6M) Calculated over the trailing 6-month period	107.73%	12.68%	+95.05%
Volatility (1Y) Calculated over the trailing 1-year period	153.97%	22.28%	+131.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	178.96%	21.16%	+157.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	178.96%	20.65%	+158.31%